Economic news
Weight-loss drug developer Metsera targets up to $1.78 billion valuation in US IPO
2025.01.27 13:13
Weight-loss drug developer Metsera targets up to $1.78 billion valuation in US IPO
Source link
2025.01.27 13:13
Weight-loss drug developer Metsera targets up to $1.78 billion valuation in US IPO
Source link